|Title:||Recommendations for rotavirus vaccine||Authors:||PING-ING LEE
|Issue Date:||2013||Journal Volume:||54||Journal Issue:||6||Start page/Pages:||355-359||Source:||Pediatrics and Neonatology||Abstract:||
Rotavirus infection has been the leading cause of gastroenteritis among children in Taiwan. Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent rotavirus vaccine and a pentavalent, human-bovine reassortant rotavirus vaccine. In 2009, the World Health Organization suggested that rotavirus vaccine should be included in all national immunization programs. This review summarizes issues and recommendations discussed during an expert meeting in Taiwan. The recommendations included: (1) rotavirus vaccine should be offered to all healthy infants (including those without contraindications, such as immunodeficiency) at an appropriate age; (2) either monovalent or pentavalent vaccine can be administered concurrently with routine injected vaccines; (3) the administration of rotavirus vaccine must be administered at least 2 weeks prior to oral polio vaccination; (4) the first vaccine dose for infants should be administered between age 6 weeks and age 14 weeks 6 days and the course should be completed by age 8 months 0 day; (5) pentavalent vaccines can be administered at 2 months, 4 months, and 6 months while monovalent vaccines can be taken at 2 months and 4 months; (6) a combined use of monovalent and pentavalent vaccine is justified only when the previous dose is unavailable or unknown; and (7) rotavirus vaccines may be given to premature infants, human immunodeficiency virus infected infants and infants who have received or are going to receive blood products. Copyright ? 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
|ISSN:||1875-9572||DOI:||10.1016/j.pedneo.2013.03.019||SDG/Keyword:||diphtheria pertussis tetanus Haemophilus influenzae type b hepatitis B vaccine; hepatitis B vaccine; oral poliomyelitis vaccine; Pneumococcus vaccine; Rotavirus vaccine; acute gastroenteritis; clinical trial (topic); cost effectiveness analysis; developing country; diarrhea; diphtheria; drug cost; drug efficacy; follow up; gastroenteritis; hepatitis B; hospitalization; human; Human immunodeficiency virus infection; immune response; immunogenicity; influenza B; lowest income group; mortality; outpatient care; pertussis; pneumococcal infection; poliomyelitis; postmarketing surveillance; prematurity; preventive health service; review; Rotavirus infection; severe combined immunodeficiency; Taiwan; tetanus; vaccination; viral gastroenteritis; diarrhea; recommendation; rotavirus infection; Taiwan; vaccine; Humans; Immunization Schedule; Infant; Rotavirus Infections; Rotavirus Vaccines; Taiwan; Vaccination
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.